Shopping Cart 0
Cart Subtotal
AED 0

Osteoporosis

Showing Repository 1-9 of 9 Reports

per page
Single User License Price
  1. Tarsa Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    20 Pages| November 2018 |
    AED 918
    Tarsa Therapeutics Inc is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases. Learn More
  2. Asahi Kasei Pharma Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    25 Pages| November 2018 |
    AED 918
    Asahi Kasei Pharma Corp, a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. Learn More
  3. Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    65 Pages| October 2018 |
    AED 918
    Mithra Pharmaceuticals SA is a developer and manufacturer of over the counter products and prescription drugs for women's health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Learn More
  4. Laboratorios Farmaceuticos Rovi SA (ROVI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    46 Pages| October 2018 |
    AED 918
    Laboratorios Farmaceuticos Rovi SA is a developer and manufacturer of prescription and hospital products. The company offers hospital products such as Iomeron and Iopamiro, Multihance, Y Prohance, Sonovue, contrast injection systems, Sodium Heparin a Learn More
  5. Italfarmaco SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    18 Pages| September 2018 |
    AED 918
    Italfarmaco SpA, a subsidiary of Italfarmaco Holding SpA, is a pharmaceutical and chemical company which develops, manufactures, commercializes, and licences pharmaceutical drugs. Learn More
  6. Mochida Pharmaceutical Co Ltd (4534) - Financial and Strategic SWOT Analysis Review

    36 Pages| September 2018 |
    AED 459
    Mochida Pharmaceutical Co Ltd is a pharmaceutical company that develops, manufactures and markets drugs and diagnostic regents. The company's drugs are used for the treatment of arteriosclerosis obliterans, hyperlipidemia, hypertension, angina pector Learn More
  7. The Menarini Group - Strategy, SWOT and Corporate Finance Report

    34 Pages| August 2018 |
    AED 642
    The Menarini Group , an Italian pharmaceutical business entity, is involved in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases; gastro-intestinal; Analgesia; gastrointestinal disorders; reumatology / oste Learn More
  8. Osteoporosis Global Clinical Trials Review, H1, 2018

    781 Pages| April 2018 |
    AED 9175

    Osteoporosis Global Clinical Trials Review, H1, 2018

    Summary

    GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H1, 2018" provides an overview of Osteoporosis clinical trials scenario. Th Learn More

  9. China Osteoporosis Market Outlook to 2017- Traditional Chinese Medicine to Steer the Growth

    108 Pages| July 2013 |
    AED 2349
    The market for osteoporosis drugs in China reached around USD 1,608.9 million in 2012. The highest contributing segment to the overall drug market is teriparatide which had a share of close to around Learn More
Loading Indicator
chat_bubbleLet's Chat